Navigation Links
November is Lung Cancer Month: Know the Latest Information About This Deadliest of Cancers
Date:10/27/2009

INDIANAPOLIS, Oct. 27 /PRNewswire-FirstCall/ -- Lung cancer is the world's most common cancer, and an estimated 219,440 Americans are expected to be diagnosed this year.(1) It is also estimated that lung cancer will cause 159,000 deaths in the United States this year - more than the total number of deaths resulting from breast, colon and prostate cancers combined.(1) Still, lung cancer lags far behind other cancers in both awareness and research funding, and, partly due to its connection with smoking, there can be a stigma attached to the disease.(2)

But there is hope for lung cancer patients. According to Richard Gaynor, M.D., vice president of oncology product development and medical affairs at Eli Lilly and Company, a leader in thoracic cancer treatment, "Researchers have made important strides in the last decade in lung cancer prevention, detection and treatment. We know that secondary smoke is detrimental.(3) We have better X-rays and spiral CT scans to detect lung cancer earlier on. And we know that where treatment is concerned, lung cancer, like breast cancer, can benefit from a tailored approach."

In the past, oncologists have used similar approaches to treatment based on lung cancer diagnosis, staging and prognosis.(4) But advances in tailored treatment options may help oncologists choose which patients could be more likely to benefit from certain therapies.

"While our work is far from finished, we do have a better understanding of lung cancer today, and patients can benefit," said Dr. Gaynor.

Prevalence and Prognosis

Lung cancer can affect any adult, including nonsmokers. Since 1985, it has risen to be the world's most common form of cancer, and an estimated 219,440 more Americans are expected to be diagnosed this year.(5) The chance that a man will develop lung cancer is about 1 in 13, and for a woman it is approximately 1 in 16.(1) Nearly 70 percent of people diagnosed with lung cancer are older than 65; fewer than three percent of all cases are found in people under the age of 45.(6)

Survival is improved the earlier a patient is diagnosed with lung cancer. With early detection, there is a 50 percent chance of surviving for five years. However, only 16 percent of cases are diagnosed at an early stage. Unfortunately, as the disease is often diagnosed at later stages, approximately 59 percent of those with lung cancer will die within the first year of diagnosis.(7)

The five-year survival rate for lung cancer has increased slightly over the last 30 years. In the mid-1970s the rate was 13 percent, as compared to the latest statistics which find the rate at 15.6 percent for the years 1999 - 2006.(8)

Symptoms

In the early stages of the disease, many people have vague or no symptoms. Persistent cough along with blood in the phlegm and shortness of breath are common symptoms of lung cancer. Sometimes, symptoms may seem unrelated to the lungs or breathing. As lung cancer is diagnosed mostly in later stages, the primary cancer may have already spread to other parts of the body. Depending upon where the cancer spreads and which organs are affected, symptoms may also include headaches, weakness of a limb, bone pain, weight loss and loss of appetite.(9)

If You are Diagnosed: What to Ask Your Oncologist(10)

  • What kind of lung cancer do I have?
  • Has my cancer spread beyond my lungs, or is it limited to my lungs only?
  • What is the stage of my cancer, and what does that mean in my case?
  • Are there other tests that need to be done before we can decide on treatment?
  • What treatment choices do I have?
  • What risks or side effects are there to the treatments you suggest?
  • How long will treatment last? What will it involve? Where will it be done?
  • What are the chances of recurrence of my cancer after treatment? And what treatments are available if it recurs?
  • Am I eligible for clinical trial?

For more information on the signs and symptoms of lung cancer, diagnostics and treatment options, please see your qualified healthcare professional.

About Lilly Oncology, a Division of Eli Lilly and Company

For more than four decades, Lilly Oncology has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. Our quest is to develop a broad portfolio of tailored therapies that accelerate the pace and progress of cancer care. To learn more about Lilly's commitment to cancer, please visit www.LillyOncology.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

(1) American Cancer Society, "What Are the Key Statistics About Lung Cancer?," October 24, 2008, American Cancer Society, http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_About_Lung_Cancer_15.asp?sitearea, (September 1, 2009).

(2) Lung Cancer Alliance, "2009 Facts About Lung Cancer," Lung Cancer Alliance, www.lungcanceralliance.org/pdf_docs/2009_Factsheet.pdf, (October 14, 2009).

(3) American Cancer Society, "Secondhand Smoke," May 22, 2009, American Cancer Society, http://www.cancer.org/docroot/PED/content/PED_10_2X_Secondhand_Smoke-Clean_Indoor_Air.asp, (September 30, 2009).

(4) National Cancer Institute, "Non-Small Cell Lung Cancer Treatment (PDQ®) Health Professional Version," July 10, 2009, National Cancer Institute, www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page2, (September 1, 2009).

(5) American Cancer Society, "How Many People Get Non-small Cell Lung Cancer?" 2009, American Cancer Society, http://www.cancer.org/docroot/CRI/content/CRI_2_2_1x_How_Many_People_Get_Non-small_Cell_Lung_Cancer.asp?sitearea= , (October 14, 2009).

(6) American Cancer Society, "What Are the Key Statistics for Small Cell Lung Cancer?." October 30, 2008, American Cancer Society, http://www.cancer.org/docroot/CRI/content/CRI_2_4_1x_What_Are_the_Key_Statistics_for_Small_Cell_Lung_Cancer.asp?sitearea, (September 1, 2009).

(7) American Cancer Society, "Cancer Facts & Figures 2009," Atlanta: 2009, www.cancer.org/docroot/STT/STT_0.asp, (October 8, 2009).

(8) National Cancer Institute, "Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program," National Cancer Institute, http://seer.cancer.gov/statfacts/html/lungb.html, (September 1, 2009).

(9) American Cancer Society, "How Is Non-Small Cell Lung Cancer Diagnosed?." October 24, 2008, American Cancer Society, http://www.cancer.org/docroot/CRI/content/CRI_2_4_3x_How_Is_Non-Small_Cell_Lung_Cancer_Diagnosed.asp?sitearea=, (October 20, 2009).

(10) American Cancer Society, "What Should You Ask Your Doctor About Non-Small Cell Lung Cancer?," October 24, 2008, American Cancer Society, http://www.cancer.org/docroot/CRI/content/CRI_2_4_5x_What_Should_You_Ask_Your_Doctor_About_Non-Small_Cell_Lung_Cancer.asp?sitearea=, (September 30, 2009).

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO)

CR-LLY

SOURCE Eli Lilly and Company


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco to Present at November 2009 Investor Conferences
2. Symmetry Medical to Report Third Quarter 2009 Financial Results on November 5, 2009
3. Uroplasty to Issue Second Fiscal Quarter Results on November 2, 2009
4. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
5. Masimo to Report Third Quarter 2009 Financial Results on November 3, 2009
6. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
7. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
8. The 60th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA -- Hynes Convention Center October 31 -- November 3, 2009
9. Opportunities to Highlight Type 1 Diabetes in November
10. Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Societys Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland)
11. CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide ... achieve significant growth as next generation systems provide ... use radiology for cancer surgery. New systems pinpoint ... overdosing that has been such a problem previously, ... delivered. Radiosurgery robots take cancer surgery far beyond ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Colorize ... on one drop zone to the next using Colorize's dynamic moving camera. Colorize is ... This package includes a 3D slideshow environment with 1 to 5 focus points per ...
(Date:2/5/2016)... ... 05, 2016 , ... On June 9-10, Las Vegas will ... education (CME) event presented by the Association for Comprehensive Care in Rare Diseases ... whose mission is to provide education, tools, and resources to primary care clinicians ...
(Date:2/5/2016)... Luis Obispo, CA (PRWEB) , ... February 05, 2016 , ... ... new changes that Medicare San Luis Obispo users can expect to see in 2016. ... , The two most significant changes will directly impact many San Luis Obispo seniors ...
Breaking Medicine News(10 mins):